HomeAI · summaries
Storia in 2 fonti
Cancer is changing. Is pharma marketing changing with it?
Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report examines key trends, gaps in care, and how data and digital strategies are evolving to meet new expectations. Download the report to learn more. | Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report examines key trends, gaps in care, and how data and digital strategies are evolving to meet new expectations. Download the report to learn more.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Real-World Evidence in the AI Era: What You Can Unlock Depends on What You Build On
Written by Guy Amster, Senior Principal Machine Learning Engineer, Flatiron Health | The differentiator isn't algorithms; it's data quality. Discover the two critical bottlenecks…
- ·
Eliminating KRAS: Why targeted protein degraders could redefine what’s possible in cancer
By Moitreyee Chatterjee-Kishore, Ph.D., MBA, Head of Oncology Development, Astellas Pharma Inc. | How targeted protein degraders could eliminate KRAS and redefine cancer care –…
